New drug meavert can prevent the growth and spread of pancreatic cancer, study says
-
Last Update: 2020-06-11
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
pancreatic cancer, one of the leading causes of cancer-related death in the United States, poses a significant threat to the public'shealthThis year, about 55,000 people in the U.Swill be diagnosed with pancreatic cancer, and more than 44,000 will die from the disease, making it one of the deadliest cancersrecent lying, a study from the Samuel Oschin Institute for Comprehensive Cancer Research in Cedars-Sinai found that a newdrug called meavert(prevents the growth and spread of the most common pancreatic cancer in laboratory mice)the study also demonstrated thattavert can prevent patients from developing resistance to chemotherapy for pancreatic cancer currently in useover a four-year period, researchers designed andsynthetic, a new chemical that inhibits the activity of cancer cellsThey found that me
tavert can block drug resistance and significantly enhance radiation and theof the drugcommonly used chemotherapy in both humansIn one mouse study, tavert increased survival by about 50 percent , the team from Cedars-Sinai is working to improve the drug so that it can be used in human experimental
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
